The Diabetes Technology Maturity Model (DTMM) is a structured framework that helps healthcare organizations evaluate their current capabilities, identify gaps, and build a clear roadmap for advancing diabetes technology integration. It supports better patient outcomes, streamlined workflows, and long-term sustainability.
Benchmark your organization’s current technology integration.
Identify and close gaps is workflows, data, and processes.
Achieve seamless, scalable, and data-driven diabetes care.
A maturity model is a structured framework that measures an organization’s capabilities in a specific area—mapping progress from the most basic stage to the most advanced. By defining clear levels, these models help teams identify where they are now, where they want to be, and the steps needed to get there. Widely used in healthcare and technology, maturity models guide strategic planning, standardize processes, and drive consistent, scalable progress.
The DTMM applies this proven approach to one of healthcare’s fastest-growing areas—diabetes technology. As tools like continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery systems, and population health platforms become central to care, organizations often face inconsistent adoption, fragmented workflows, and underused data. DTMM offers a clear, evidence-informed roadmap to close these gaps, align teams, and maximize both clinical and financial impact.
Ensure technology investments directly support better outcomes.
Standardize processes to reduce variability and improve efficiency.
Use data and feedback to scale the right technologies, faster.
The Diabetes Technology Maturity Model (DTMM) is built on two key elements:
Six Domains – The critical focus areas that determine how effectively your organization adopts, integrates, and optimizes diabetes technologies.
Six Maturity Levels – A progressive scale that measures your organization’s current capabilities and maps the pathway to higher performance.
By combining these, DTMM provides a clear, structured approach to evaluate where you are today, set targeted goals, and measure your progress over time. The result: aligned teams, smarter technology use, and better outcomes for patients living with diabetes.
The DTMM is designed to be simple to adopt and meaningful in practice. Whether you’re evaluating your current technology integration or planning for future investments, the model can guide your team through a structured self-assessment and improvement process.
Review the Model
Familiarize your team with the six domains and six maturity levels.
Form a Multidisciplinary Team
Include representatives from clinical care, operations, IT, finance, and quality improvement.
Score Your Organization
Use the DTMM rubric to assess your current maturity level in each domain.
Identify Gaps and Priorities
Pinpoint where your performance can improve and where the biggest opportunities lie.
Create an Action Plan
Set specific goals, timelines, and metrics to progress to the next maturity level.
Reassess Regularly
Track progress annually—or more frequently during major initiatives.
Clinical leaders, frontline clinicians, IT/data teams, operations, finance/revenue cycle, and innovation/quality teams involved in diabetes technology adoption and integration.
Yes. The model and self‑assessment are available at no cost for healthcare organizations.
Typically 30–60 minutes with a small multidisciplinary group (clinical, IT, ops, finance/QI).
At least annually; consider quarterly during major initiatives or after adopting new technologies.
A domain-by-domain maturity profile (Levels 1–6), prioritized gaps, and a clear roadmap to advance to the next level.
Yes. Keep the six domains/levels, but tailor scoring notes, evidence, and action plans to your workflows, EHR, and resources.
No—DTMM complements them by providing a technology-specific structure; use your preferred QI methods to execute improvements.
Example policies/SOPs, workflow maps, EHR screenshots, training materials, billing/coding reports, analytics dashboards, and any device support processes.
Involve multiple roles, require examples/evidence for each rating, default to the lower level if between two, and document rationale.
The Rising T1DE Alliance, in collaboration with clinical, informatics, and analytics leaders; the model is iteratively refined with community feedback.
No patient-level data is collected by the model itself. Any internal evidence you review stays within your organization.
Use the guide and self-assessment, then reach out for advisory support or to join community validation efforts.
Rising T1DE Alliance Diabetes Technology Maturity Model would not have been possible without the financial support of the
Leona M. and Harry B. Helmsley Charitable Trust